French drugmaker Sanofi has started a process to turn its India consumer healthcare business into a listed entity via a demerger, the Economic Times newspaper reported on Friday.
The company is working with Bank of America on the spin-off process, ET reported, citing people familiar with the matter.
Sanofi India did not immediately respond to a Reuters’ request for comment.
About 60% of Sanofi India is owned by Sanofi and its wholly owned subsidiary Hoechst Gmbh, while the rest is held by foreign and domestic institutional and retail investors, the report said, adding that the consumer business would be listed separately with a similar shareholding pattern.
(Reporting by Jyoti Narayan in Bengaluru; editing by Uttaresh Venkateshwaran)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.
Also read: Sanofi cuts insulin prices by up to 78 PC